EUVIMEDEUVIMED entdecken
Crossref

Clear Cell Renal Cell Carcinoma: Characterizing the Phenotype of Von Hippel–Lindau Mutation Using MRI

Xu Bai iD, Cheng Peng, Baichuan Liu, Shaopeng Zhou, Huiping Guo, Yuwei Hao, Haili Liu, Yijian Chen, Xin Liu, Xueyi Ning, Yuanhao Ma, Jian Zhao und 4 weitere

Journal of Magnetic Resonance Imaging · 2025

DOI: 10.1002/jmri.29588 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Magnetic Resonance Imaging, 2025. Verfasst von Xu Bai und 15 weiteren Autor:innen. Beteiligte Einrichtung: Medical School of Chinese PLA, Beijing, China. Hauptthemen laut MEDLINE: Carcinoma, Renal Cell, Magnetic Resonance Imaging, Kidney Neoplasms, Von Hippel-Lindau Tumor Suppressor Protein. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 39 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Youth Independent Innovation Science Foundation of Chinese PLA General Hospital.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

The von Hippel–Lindau (VHL) mutation is an important alteration in clear cell renal cell carcinoma (ccRCC); however, its imaging phenotype remains unclear.

Purpose

To investigate whether MRI features can reflect the VHL mutation status. Study Type Retrospective. Field Strength/Sequence 3 T/fast spin echo T2‐weighted, spin‐echo echo planar diffusion‐weighted, gradient recalled echo T1‐weighted, gradient recalled echo chemical‐shift T1‐weighted, and contrast‐enhanced gradient recalled echo T1‐weighted sequences. Population One hundred five patients with ccRCC who underwent preoperative contrast‐enhanced MRI and subsequent genomic sequencing: 59 consecutive patients from our institution (38 [64.41%] with VHL mutations) formed a training cohort, and 46 from The Cancer Genome Atlas (TCGA) database (24 [52.17%] with VHL mutations) formed an independent test cohort. Assessment Two radiologists, with 23 and 33 years of experience respectively, jointly evaluated the semantic MRI features of the primary lesion in ccRCCs to propose potential features related to VHL mutations in both cohorts. Three additional readers, with 5, 7, and 10 years of experience respectively, independently reviewed all lesions to assess the interobserver agreement of MRI features. A VHL mutational likelihood score (VHL‐MULIS) system was constructed using the training cohort and validated using the independent test cohort. Statistical Tests Fisher's test or chi‐square test, t ‐test or Mann–Whitney U test, logistic regression, Cohen's kappa ( κ ), area under the receiver operating characteristic curve (AUC). A two‐sided P value

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Carcinoma, Renal CellMagnetic Resonance ImagingKidney NeoplasmsVon Hippel-Lindau Tumor Suppressor Proteinvon Hippel-Lindau DiseaseHumansFemaleMaleMiddle AgedMutationPhenotypeRetrospective StudiesAdultAgedContrast MediaROC Curve

Stichwörter der Autor:innen

clear cell renal cell carcinomaphenotypesomatic mutationvon Hippel–Lindau

Substanzen

Von Hippel-Lindau Tumor Suppressor ProteinVHL protein, humanContrast Media

Autor:innen und Institutionen

  • Medical School of Chinese PLA, Beijing, China.
  • Department of Radiology, First Medical Center, Chinese PLA General Hospital, Beijing, China.
  • Department of Radiology, Fifth Medical Center, Chinese PLA General Hospital, Beijing, China.
  • Department of Urology, First Medical Center, Chinese PLA General Hospital, Beijing, China.
  • Department of Radiology, Fourth Medical Center, Chinese PLA General Hospital, Beijing, China.
  • Department of Radiology, Chinese PLA 920 Hospital, Kunming, China.

ORCID-Profile: Xu Bai, Haiyi Wang

Förderung

  • National Natural Science Foundation of China
  • Youth Independent Innovation Science Foundation of Chinese PLA General Hospital

Zitieren

APA

Bai, X., Peng, C., Liu, B., Zhou, S., Guo, H., Hao, Y., Liu, H., Chen, Y., Liu, X., Ning, X., Ma, Y., Zhao, J., Li, L., Ye, H., Ma, X., & Wang, H. (2025). Clear Cell Renal Cell Carcinoma: Characterizing the Phenotype of Von Hippel–Lindau Mutation Using MRI. Journal of Magnetic Resonance Imaging. https://doi.org/10.1002/jmri.29588

Vancouver

Bai X, Peng C, Liu B, Zhou S, Guo H, Hao Y, et al. Clear Cell Renal Cell Carcinoma: Characterizing the Phenotype of Von Hippel–Lindau Mutation Using MRI. Journal of Magnetic Resonance Imaging. 2025. doi:10.1002/jmri.29588

BibTeX
@article{Bai2025,
  author = {Bai, Xu and Peng, Cheng and Liu, Baichuan and Zhou, Shaopeng and Guo, Huiping and Hao, Yuwei and Liu, Haili and Chen, Yijian and Liu, Xin and Ning, Xueyi and Ma, Yuanhao and Zhao, Jian and Li, Lin and Ye, Huiyi and Ma, Xin and Wang, Haiyi},
  title = {Clear Cell Renal Cell Carcinoma: Characterizing the Phenotype of Von Hippel–Lindau Mutation Using MRI},
  journal = {Journal of Magnetic Resonance Imaging},
  year = {2025},
  doi = {10.1002/jmri.29588}
}
Kostenlos starten →